Chronic Pulmonary Hypertension Diagnostic Market is segmented By Drug Class (Endothelin Receptor Antagonists, Phosphodiesterase-5 Inhibitors, Prostacyclin Analogues, Soluble Guanylate Cyclase Stimulators), By Disease Type (Pulmonary Arterial Hypertension, Chronic Thromboembolic Pulmonary Hypertension, Hypoxic Pulmonary Hypertension, Pulmonary Venous Hypertension), By Route of Administration (Oral, Injectable, Inhalation), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa). The report offers the value (in USD billion) for the above-mentioned segments.(2025-2032)
Excel Databook (Quantitative Data Only)
$2,000
Two thousand two hundred dollars
PDF Report and Excel Databook (Both)
Single User License
(1 User)
$4,500
$3,000
Three thousand two hundred fifty dollars
Frequently Purchased
PDF Report and Excel Databook (Both)
Multi User License
(up to 7 Users)
$7,000
$5,000
Five thousand two hundred fifty dollars
PDF Report and Excel Databook (Both)
Corporate User License
(Unlimited Users)
$10,000
$6,000
Six thousand seven hundred fifty dollars